Patents by Inventor Da Yeon Kim
Da Yeon Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240179993Abstract: A transparent display device comprises: a first substrate including a display area and first to fourth bezel areas surrounding the display area, wherein the display area includes a plurality of pixel regions each including an emitting portion and a transparent portion; a second substrate facing the first substrate; a transparent dam between the first and second substrates and in the first to fourth bezel areas; a first pad electrode on the first substrate and in the first bezel area; and a first color filter pattern on the second substrate and in the first bezel area.Type: ApplicationFiled: February 8, 2024Publication date: May 30, 2024Applicant: LG DISPLAY CO., LTD.Inventors: Da-Woon JEONG, Su-Yeon LEE, Sung-Hee KIM, Jae-Bin SONG, Sung-Hee PARK
-
Publication number: 20240148856Abstract: Provided is a vaccine composition for preventing respiratory syncytial virus (RSV) infection, which is in the form of a liposome formulation including a RSV antigen, monophosphoryl lipid A (MLA), and/or a cobalt-porphyrin-phospholipid (CoPoP) conjugate. The vaccine composition exhibits excellent vaccine efficacy from a RSV antigen with enhanced immunogenicity and a combination of immune adjuvants for enhancing immune activity and antigen presentation.Type: ApplicationFiled: October 26, 2023Publication date: May 9, 2024Applicant: EUBIOLOGICS CO., LTD.Inventors: Chan Kyu LEE, Jonathan F. LOVELL, Yoon Hee WHANG, Woo Yeon HWANG, Hye Ji KIM, Min Chul PARK, Seok Kyu KIM, Wei-Chiao HUANG, Da Hui HA
-
Patent number: 11963423Abstract: A transparent display device comprises: a first substrate including a display area and first to fourth bezel areas surrounding the display area, wherein the display area includes a plurality of pixel regions each including an emitting portion and a transparent portion; a second substrate facing the first substrate; a transparent dam between the first and second substrates and in the first to fourth bezel areas; a first pad electrode on the first substrate and in the first bezel area; and a first color filter pattern on the second substrate and in the first bezel area.Type: GrantFiled: June 3, 2021Date of Patent: April 16, 2024Assignee: LG DISPLAY CO., LTD.Inventors: Da-Woon Jeong, Su-Yeon Lee, Sung-Hee Kim, Jae-Bin Song, Sung-Hee Park
-
Patent number: 11961750Abstract: A magnetic transfer apparatus includes: a magnetomotive force source providing magnetic flux, a first magnetic flux distribution circuit connected to one end of the magnetomotive force source, having a single input terminal and a plurality of output terminals, and distributing the magnetic flux, and a second magnetic flux distribution circuit connected to the other end of the magnetomotive force source, having a single output terminal and a plurality of input terminals, and collecting the distributed magnetic flux. The output terminals of the first magnetic flux distribution circuit are disposed to be adjacent to each other to form a pair with the input terminals of the second magnetic flux distribution circuit.Type: GrantFiled: November 29, 2021Date of Patent: April 16, 2024Assignee: KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATIONInventors: Tae-Yeon Seong, Da-Hoon Lee, Jong-Ho Kim
-
Publication number: 20230385533Abstract: Provided is a method for providing an edit service of a document, performed by at least one processor. The method includes storing, in a first data queue, first edit data received from a first communication terminal; storing, in the first data queue, second edit data received from a second communication terminal; updating an online document by reflecting the first edit data and the second edit data stored in the first data queue in the online document; transmitting the first edit data to the second communication terminal; and transmitting the second edit data to the first communication terminal.Type: ApplicationFiled: May 31, 2023Publication date: November 30, 2023Applicant: SAMSUNG SDS CO., LTD.Inventors: Da Yeon KIM, Tae Hwang YOO, Ji Won OK, Bin Na LEE, Jong In IM, Kyu Bum CHOI
-
Publication number: 20220382660Abstract: A method of generating action history data of an application according to an embodiment of the present disclosure is performed by a computing device. The method includes acquiring a first log generated by an application, acquiring a second log generated by a database (DB), matching application log entries included in the first log to DB log entries included in the second log, and generating action history data about actions performed by the application on the basis of a result of the matching.Type: ApplicationFiled: May 27, 2022Publication date: December 1, 2022Inventors: Tae Hwang YOO, Bin Na LEE, Da Yeon KIM, Ji Won OK
-
Publication number: 20210162094Abstract: Provided is a two-liquid type hemostatic composition that may be used adjunctively during a wide range of bleeding events and surgeries, and a method for preparing the same. The two-liquid type hemostatic composition does not contain blood products, comprises a first solution containing chitosan and a second solution containing a glucose or cellulose compound, may be easily applied in a liquid form to a wound or surgical bleeding site of the human body, and may help hemostasis and recovery by immediately forming a hydrogel at the bleeding area.Type: ApplicationFiled: May 10, 2019Publication date: June 3, 2021Inventors: Da Yeon KIM, Min Eui HAN, Ki Su PARK, Ji Hoon JOO, Eun Kyung YANG
-
Patent number: 10894895Abstract: The present invention provides a two-component bioink including a first solution and a second solution separately, wherein (i) the first solution includes a first biopolymer to which a first chemical functional group is introduced, and the second solution includes a second biopolymer to which a second chemical functional group able to chemically bond with the first chemical functional group is introduced; or (ii) the first solution includes a third biopolymer having a first electrostatic functional group, and the second solution includes a fourth biopolymer having a second electrostatic functional group able to physically bond with the first electrostatic functional group, a 3D biomaterial including the same, and a method for preparing the same.Type: GrantFiled: June 27, 2016Date of Patent: January 19, 2021Assignee: AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Kyung Sook Kim, Da Yeon Kim, Seung Hun Park, Ja Yong Jang, Moon Suk Kim
-
Patent number: 10307373Abstract: Provided is a drug delivery system for control of initial burst of a drug. More particularly, there are provided a drug delivery formulation including: a granule containing a biodegradable polymer and a drug; and a temperature-sensitive hydrogel, and a method for preparing the same. The presently disclosed drug delivery formulation can be prepared via a relatively simple process and allows a drug to be released slowly at a constant rate without initial burst and thus maintains a constant blood level of the drug for a long period of time. Consequently, it is capable of preventing the initial burst of the existing injection-type drug delivery formulations and slow-release granules and providing a desired release profile, including sustained release with time.Type: GrantFiled: February 8, 2011Date of Patent: June 4, 2019Assignee: AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Moon Suk Kim, Da Yeon Kim
-
Publication number: 20180215934Abstract: The present invention provides a two-component bioink including a first solution and a second solution separately, wherein (i) the first solution includes a first biopolymer to which a first chemical functional group is introduced, and the second solution includes a second biopolymer to which a second chemical functional group able to chemically bond with the first chemical functional group is introduced; or (ii) the first solution includes a third biopolymer having a first electrostatic functional group, and the second solution includes a fourth biopolymer having a second electrostatic functional group able to physically bond with the first electrostatic functional group, a 3D biomaterial including the same, and a method for preparing the same.Type: ApplicationFiled: June 27, 2016Publication date: August 2, 2018Applicant: AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Kyung Sook KIM, Da Yeon KIM, Seung Hun PARK, Ja Yong JANG, Moon Suk KIM
-
Publication number: 20140328939Abstract: The present invention relates to a method for preparing a biocompatible small intestinal submucosa hydrogel with a controllable in-vivo degradation period, more particularly to a method for preparing a small intestinal submucosa hydrogel which is formed in a solution phase by forming chemical crosslinkages by solubilizing a biocompatible small intestinal submucosa powder and allows the degradation period of a gel formed during in-vivo injection by controlling the degree of crosslinking and a method for preparing a small intestine submucosa drug carrier or a small intestine submucosa support using the hydrogel.Type: ApplicationFiled: April 2, 2012Publication date: November 6, 2014Applicant: AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Da Yeon Kim, Moon Suk Kim, So Mi Yoon, Bit Na Lee
-
Publication number: 20120177740Abstract: Provided is a drug delivery system for control of initial burst of a drug. More particularly, there are provided a drug delivery formulation including: a granule containing a biodegradable polymer and a drug; and a temperature-sensitive hydrogel, and a method for preparing the same. The presently disclosed drug delivery formulation can be prepared via a relatively simple process and allows a drug to be released slowly at a constant rate without initial burst and thus maintains a constant blood level of the drug for a long period of time. Consequently, it is capable of preventing the initial burst of the existing injection-type drug delivery formulations and slow-release granules and providing a desired release profile, including sustained release with time.Type: ApplicationFiled: February 8, 2011Publication date: July 12, 2012Applicant: AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATIONInventors: Moon Suk Kim, Da Yeon Kim